Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era.

@article{Jacob2005DesignOA,
  title={Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era.},
  author={Sonia Jacob and David Jacques Cohen and Joseph Massaro and Paulette Niemyski and Kelly Maresh and Neal S. Kleiman},
  journal={American heart journal},
  year={2005},
  volume={150 5},
  pages={887-92}
}
BACKGROUND Clinical trials have shown drug-eluting stents (DES) to be superior to bare metal stents (BMS) in preventing in-stent restenosis and target vessel revascularization. Although these results have ushered in a sea change in the practice of myocardial revascularization, important questions remain unanswered concerning rates of ischemic complications when DES are used in a broader population not represented in the clinical trials. STUDY DESIGN The EVENT registry will include 7500 to 10… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…